首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion
【24h】

MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion

机译:MITO-Porter:一种基于脂质体的载体系统,用于通过膜融合将大分子递送至线粒体

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mitochondria are the principal producers of energy in higher cells. Mitochondrial dysfunction is implicated in a variety of human diseases, including cancer and neurodegenerative disorders. Effective medical therapies for such diseases will ultimately require targeted delivery of therapeutic proteins or nucleic acids to the mitochondria, which will be achieved through innovations in the nanotechnology of intracellular trafficking. Here we describe a liposome-based carrier that delivers its macromolecular cargo to the mitochondrial interior via membrane fusion. These liposome particles, which we call MITO-Porters, carry octaarginine surface modifications to stimulate their entry into cells as intact vesicles (via macropinocytosis). We identified lipid compositions for the MITO-Porter which promote both its fusion with the mitochondrial membrane and the release of its cargo to the intra-mitochondrial compartment in living cells. Thus, the MITO-Porter holds promise as an efficacious system for the delivery of both large and small therapeutic molecules into mitochondria. (c) 2007 Elsevier B.V All rights reserved.
机译:线粒体是高等细胞中能量的主要产生者。线粒体功能障碍与多种人类疾病有关,包括癌症和神经退行性疾病。针对此类疾病的有效医学疗法最终将需要将治疗性蛋白质或核酸靶向递送至线粒体,这将通过细胞内运输纳米技术的创新来实现。在这里,我们描述了一种基于脂质体的载体,该载体通过膜融合将其大分子货物传递到线粒体内。这些脂质体颗粒(我们称为MITO-Porters)具有八精氨酸表面修饰,可刺激它们作为完整的囊泡进入细胞(通过巨胞饮作用)。我们确定了MITO-Porter的脂质成分,该成分既促进其与线粒体膜的融合,又促进其货物释放至活细胞中的线粒体内。因此,MITO-Porter有望成为一种有效的系统,可将大分子和小分子治疗分子同时传递到线粒体中。 (c)2007 Elsevier B.V保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号